Drug approval
Drug approval is a process that involves the regulatory authorities' authorization for the marketing of a drug or medication after a thorough examination of its safety, efficacy, and quality. This process is crucial in ensuring that the drugs available to the public are safe and effective.
Overview[edit | edit source]
The drug approval process begins with the discovery and development of a new drug. This involves extensive laboratory testing and preclinical trials. Once the drug has shown promise in these initial stages, it moves on to clinical trials, which are conducted in several phases. The data from these trials is then submitted to the regulatory authorities for review.
Drug Discovery and Development[edit | edit source]
The process of drug discovery involves the identification of potential new drugs from natural sources, genetic engineering, or artificial synthesis in a laboratory. Once a potential drug has been identified, it undergoes development, which involves laboratory and animal testing to determine its safety and efficacy.
Clinical Trials[edit | edit source]
Clinical trials are conducted in several phases. Phase I trials involve a small group of healthy volunteers and aim to determine the drug's safety, dosage, and side effects. Phase II trials involve a larger group of patients and aim to assess the drug's efficacy and side effects. Phase III trials involve a large group of patients and aim to confirm the drug's efficacy, monitor its side effects, compare it to commonly used treatments, and collect information that will allow the drug to be used safely.
Regulatory Review and Approval[edit | edit source]
Once the clinical trials are complete, the data is submitted to the regulatory authorities for review. This review process involves a thorough examination of the drug's safety, efficacy, and quality. If the regulatory authorities are satisfied with the data, they will approve the drug for marketing.
Post-Marketing Surveillance[edit | edit source]
After a drug has been approved and is on the market, it undergoes post-marketing surveillance. This involves monitoring the drug's performance in the general population and reporting any adverse reactions or side effects that were not identified in the clinical trials.
See Also[edit | edit source]
References[edit | edit source]
| Drug approval Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
